Omaveloxolone for the treatment of Friedreich ataxia: clinical trial results and practical considerations-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Omaveloxolone for the treatment of Friedreich ataxia: clinical trial results and practical considerations

Published:2024-01-25 Issue: Volume: Page:1-8
ISSN:1473-7175
Container-title:Expert Review of Neurotherapeutics
language:en
Short-container-title:Expert Review of Neurotherapeutics

Author:

Lynch David R¹,Perlman Susan²,Schadt Kim³

Affiliation:

1. Friedrech Ataxia Program, Division of Neurology, The Children’s Hospital of Philadelphia, Philadelphia, PA, USA

2. Department of Neurology, David Geffen UCLA School of Medicine, Los Angeles, CA, USA

3. Friedreich Ataxia Program, Division of Neurology, The Children’s Hospital of Philadelphia, Philadelphia, PA, USA

Funder

No funding

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Neurology (clinical),General Neuroscience

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737175.2024.2310617

Reference76 articles.

1. Bidichandani SI, Delatycki MB. Friedreich Ataxia. In: Adam M, Mirzaa G, Pagon R, Wallace S, Bean L, Gripp K Amemiya A, editors. GeneReviews® [internet]. Seattle (WA): University of Washington, Seattle; 1998 Dec 18 [updated 2017 Jun 1]. p. 1993–2023.

2. Friedreich's Ataxia: Autosomal Recessive Disease Caused by an Intronic GAA Triplet Repeat Expansion

3. Friedreich Ataxia: Multidisciplinary Clinical Care

4. Epigenetic promoter silencing in Friedreich ataxia is dependent on repeat length

5. DNA sequence-specific polyamides alleviate transcription inhibition associated with long GAA{middle dot}TTC repeats in Friedreich's ataxia

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP